FRIDAY EARLY AFTERNOON SYMPOSIUM 2 (F2SP2): 3.00 PM - 4.30 PM
New Developments in Schema Therapy Part 2
by Marleen Rijkeboer, Robert Brockman, Michiel Boog, Marjolein Van Wijk-Herbrink, & Richard Vuyk
Title: Schema therapy for Borderline Personality Disorder and Alcohol Use Disorder
Presenter's Name: dr. Michiel Boog
Title: Schema Therapy in adolescents with externalizing behavior problems: Bridging theory and practice
Presenter's Name: dr. Marjolein van Wijk-Herbrink
Title: Schema Therapy for Dissociative Identity Disorder
Presenter's Name: prof. dr. Marleen Rijkeboer
Dissociative Identity Disorder (DID) is a complex, severe, and highly disabling disorder that is associated with reported childhood trauma. Patients suffering from DID report to experience several identity states, and they tend to regularly switch between these identity states. Also, they frequently report experiences of depersonalization, derealization, and inter-identity amnesia. However, experimental studies have indicated that memory and identity functioning is much less compartmentalized than previously thought. Hitherto, effect studies of DID treatment are scarce, and results indicate that it is suboptimal (e.g., lengthy, high drop-out rates, in many cases stabilization only). Whilst Schema Therapy (ST) has established effectiveness in other trauma-related disorders, and the model acknowledges the subjective experience of different modes, ST seems a feasible option for DID treatment. Therefore, we developed an adapted form of ST for DID, which is currently tested in a multiple baseline case series design. In this presentation we will discuss the experimental research into inter-identity cognitive functioning that functioned as the background for developing schema therapy for DID. We will also explain the main adaptations that were made to schema therapy for trauma-related disorders specifically for these dissociative patients. The mode model offers a viable treatment alternative, and first observations with ST for DID are positive, e.g., shifting between modes becomes less extreme, and daily functioning improves. ST is a promising treatment for DID, whilst it is in line with experimental research into the nature of DID, and it helps patients to normalize their symptoms while providing an explanation for the subjective experience of separate identities.
Title: Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: results of a concurrent multiple-baseline case series study
Presenter's Name: Richard Vuyck
Background: To our knowledge treatment of personality disorder (PD) comorbidity in adults with ASD is understudied and is still in its infancy. This study investigates the effectiveness of schema therapy for PD-psychopathology in adult patients with both ASD and PD.
About the Presenters:
Marleen Rijkeboer Chair
Marleen Rijkeboeris a clinical psychologist and psychotherapist. She is an Advanced Certified Schema Therapist, Supervisor and Trainer. Marleen is a special professor for personality disorders at the Department of Clinical Psychological Science on the Faculty of Psychology and Neuroscience at Maastricht University in the Netherlands.
Robert Brockman is a Clinical Psychologist and senior research fellow at the Institute for Positive Psychology and Education,Australian Catholic University. He is also principle Clinical Psychologist atSchema Therapy Sydney, a Sydney based psychology clinic focused on the practice and dissemination of schema therapy.His clinical practice and research has largely focused on the applicability of schema therapy to novel treatment populations (e.g. Eating Disorders, GAD, Psychotic Symptoms), and the integration of 3rd Wave Therapy techniques into Schema Therapy practice
Marjolein Van Wijk-Herbrink:
Marjolein van Wijk-Herbrink is a Dutch schema therapist who obtained her PhD in Schema Therapy with adolescents with severe behavior problems. She works in court-mandated, secure residential care, where she applies individual schema therapy, and trains and coaches youth care workers to work with Schema Therapy based principles and techniques. She is a member of the executive board of the Dutch Schema Therapy association.
©2019 International Society of Schema Therapy e.V.
International Society of Schema Therapy e.V. is a not-for-profit organization. Glossop-Ring 35, DE-61118 Bad Vilbel, Germany